the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes. http://lm360.us/Treadway-grandpa-of-Romash-from-Modelia?Wasikson=82
-
.
.
- . may 17, 2018 .
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful .
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people. .